Q: Any change in your view of this name since April.
Any potential through acquisitions in the next year or two?
Any potential through acquisitions in the next year or two?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Do you have any thoughts on CleanSpark (CLSK)... I notice that the stock has been moving . Thanks
Tom
Tom
Q: Hello, could you please provide your members with your opinion and outlook on this Cdn small cap? Thanks again
Q: Atara Biotherapeutics (NASDAQ:ATRA) has announced presentation of preclinical data of ATA3219 at American Society of Hematology.
Their allogeneic CAR T-cell therapy targeting CD19, Bayer has also just entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors with Atara.
What is your opinion on this company and it's medium and long term investment potential.
Their allogeneic CAR T-cell therapy targeting CD19, Bayer has also just entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors with Atara.
What is your opinion on this company and it's medium and long term investment potential.
Q: bought at a higher price ... should I average down (sometimes not a good idea) but I am considering this option ... your thoughts
Q: Hi there,
So another stock that's popped up on my radar thanks to Twitter. KBNT - have you heard of it? Any thoughts on it? Currently have a small holding in my TFSA, shall I add? Morningstar thinks its under FV. Many thanks as always.
So another stock that's popped up on my radar thanks to Twitter. KBNT - have you heard of it? Any thoughts on it? Currently have a small holding in my TFSA, shall I add? Morningstar thinks its under FV. Many thanks as always.
-
Strathcona Resources Ltd. (SCR)
-
Good Natured Products Inc. (GDNP)
-
Xebec Adsorption Inc. (XBC)
-
Greenlane Renewables Inc. (GRN)
Q: Hello Peter,
With Xebec's bought deal at $5.80 per share with latest acquisition of Hygear, why are investors paying over $7 today? What am I missing? Would green renewables be a good bet given what is happening to Xebec? Also, why is Score dipping given the positive news on its outlook. Also, is good natured products a stock worth dipping into ? Thanks very much.
With Xebec's bought deal at $5.80 per share with latest acquisition of Hygear, why are investors paying over $7 today? What am I missing? Would green renewables be a good bet given what is happening to Xebec? Also, why is Score dipping given the positive news on its outlook. Also, is good natured products a stock worth dipping into ? Thanks very much.
Q: Hello
MTRX and KABN stock prices are exploding upwards. Apparently the companies interact. Any insights into the reason for the price action, nature of company interaction and merit/substance behind the striking moves.
MTRX and KABN stock prices are exploding upwards. Apparently the companies interact. Any insights into the reason for the price action, nature of company interaction and merit/substance behind the striking moves.
Q: If you were to buy one today for growth prospects only, which would it be?
Q: Good day, can you please comment on IPA. They appear to have lots going on at the moment. They are also planning on listing on the Nasdaq imminently while staying listed on the venture. Would you assume a capital raise will coincide with this move? Can you describe the process of dual listing?
Cheers
Cheers
Q: EnviroLeach ETI Could I please get your thoughts on this company and it's potential?
Thank you,
Kevin
Thank you,
Kevin
Q: Fandom FDM is up 70% in last two days. Wots happening
Q: The market obviously enjoyed this morning's Largo Clean Energy announcement. What is your take on it?
Q: Dear 5i,
I have questions about BABY listed on venture exchange.
This appears to be a holding company listed on the venture exchange but, the company resides in Israel. Can you explain why they might have this structure? The company doesn't look like it makes money yet and it seems heavily promotional and they also appear to do a lot of equity issues. Should one be cautious about these stories? It sounds like they have a licensing agreement to sell and existing product already in Israel to the North American market. If one were to invest 2% would you purchase in a NonReg or TFSA account? Please deduct points as required and thanks.
I have questions about BABY listed on venture exchange.
This appears to be a holding company listed on the venture exchange but, the company resides in Israel. Can you explain why they might have this structure? The company doesn't look like it makes money yet and it seems heavily promotional and they also appear to do a lot of equity issues. Should one be cautious about these stories? It sounds like they have a licensing agreement to sell and existing product already in Israel to the North American market. If one were to invest 2% would you purchase in a NonReg or TFSA account? Please deduct points as required and thanks.
Q: Any thoughts or opinions on Mitek Systems please and thank you.
Q: Hello 5i, my question is regarding the purchase of IPF by GDNP.
Do you think it is likely that GDNP would use IPF to expand production of their own plant based products or are they just buying sales of existing IPF products. I see the huge potential of their plant based products and increased production capacity being needed.
Thank you for your help
Dave
Do you think it is likely that GDNP would use IPF to expand production of their own plant based products or are they just buying sales of existing IPF products. I see the huge potential of their plant based products and increased production capacity being needed.
Thank you for your help
Dave
Q: Had a great Q resulting in a huge jump.Please comment on the Q.Is this an entry point? Txs for u usual great services & views
Q: CRS do you have any info on this co. the shares moved from .50to .74 last Fri.
Q: Hi there,
DMTK I came across DermTech listening to a MF US stock advisor live session on 10X opportunities. I spent some time reviewing their most recent earnings transcript and other research and the technology for non invasive detection of skin cancer seems powerful but super early in terms of adoption (a brief excerpt is below). I am considering buying for TFSA and have the following questions:
1. What is your general opinion?
2. Do you have any information on how a dermatologist would be paid for using this test vs surgery? My fear would be that the tech is amazing but dermatologists may not use it if it would reduce their revenue
"Currently, approximately 25 surgical biopsies are performed to find one melanoma. And despite all this cutting, the negative predictive value of this pathway is only about 83%, which means the probability of missing melanoma is approximately 17%. The PLA reduces the number of surgical biopsies needed to identify melanomas by approximately 10-fold and increases the negative predictive value so 99%, meaning the PLA has less than 1% probability of missing the disease. DermTech is effectively bringing melanoma diagnosis into the 21st century by transforming it from a pathway to subjective, invasive, inaccurate and costly to one that is objective, non-invasive, highly accurate, and less costly."
DMTK I came across DermTech listening to a MF US stock advisor live session on 10X opportunities. I spent some time reviewing their most recent earnings transcript and other research and the technology for non invasive detection of skin cancer seems powerful but super early in terms of adoption (a brief excerpt is below). I am considering buying for TFSA and have the following questions:
1. What is your general opinion?
2. Do you have any information on how a dermatologist would be paid for using this test vs surgery? My fear would be that the tech is amazing but dermatologists may not use it if it would reduce their revenue
"Currently, approximately 25 surgical biopsies are performed to find one melanoma. And despite all this cutting, the negative predictive value of this pathway is only about 83%, which means the probability of missing melanoma is approximately 17%. The PLA reduces the number of surgical biopsies needed to identify melanomas by approximately 10-fold and increases the negative predictive value so 99%, meaning the PLA has less than 1% probability of missing the disease. DermTech is effectively bringing melanoma diagnosis into the 21st century by transforming it from a pathway to subjective, invasive, inaccurate and costly to one that is objective, non-invasive, highly accurate, and less costly."
Q: Hi, any news causing the drop of MGNI today? Are there any reasons for long term concerns?
Thank-you.
Thank-you.